Total planned funding: $781,543,120
Clear active filters
University
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Mozambique | $159,859,506 |
Kenya | $116,292,294 |
Tanzania | $89,868,214 |
South Africa | $87,882,990 |
Malawi | $57,365,894 |
Uganda | $54,645,317 |
Zambia | $41,400,198 |
Côte d'Ivoire | $25,812,949 |
Botswana | $21,968,903 |
Democratic Republic of the Congo | $18,685,606 |
Ethiopia | $18,271,520 |
Eswatini | $14,067,591 |
Haiti | $12,051,012 |
Namibia | $12,012,644 |
Lesotho | $8,601,322 |
South Sudan | $8,047,655 |
Rwanda | $7,579,646 |
Nigeria | $5,477,071 |
Angola | $4,715,000 |
Vietnam | $4,550,886 |
Zimbabwe | $3,836,468 |
Ukraine | $3,500,000 |
Cameroon | $1,740,000 |
Central Asia Region | $1,051,915 |
India | $900,000 |
Burundi | $600,000 |
Caribbean Region | $300,000 |
Guyana | $258,519 |
Ghana | $150,000 |
Asia Regional Program | $50,000 |
Central America Region | $0 |
Dominican Republic | $0 |
Organizational Types
University | $781,543,120 |
Program Areas
Treatment | $270,095,437 |
Prevention | $228,955,297 |
Care | $117,708,682 |
Governance and Systems | $102,454,451 |
Testing | $62,179,253 |
Budget Codes
HTXS: Treatment: Adult Treatment | $232,165,808 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $127,079,357 |
HVCT: Testing: HIV Testing and Counseling | $62,179,253 |
HVSI: Strategic Information | $56,390,911 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $49,487,098 |
HBHC: Care: Adult Care and Support | $45,697,208 |
HVOP: Sexual Prevention: Other Sexual Prevention | $40,299,386 |
PDTX: Treatment: Pediatric Treatment | $37,829,629 |
OHSS: Health Systems Strengthening | $35,421,049 |
HVTB: Care: TB/HIV | $27,302,305 |
PDCS: Care: Pediatric Care and Support | $22,838,414 |
HKID: Care: Orphans and Vulnerable Children | $21,870,755 |
HLAB: Laboratory Infrastructure | $10,642,491 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $6,847,432 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $3,364,681 |
HMIN: Biomedical Prevention: Injection Safety | $1,063,063 |
HMBL: Biomedical Prevention: Blood Safety | $814,280 |
HTXD: Treatment: ARV Drugs | $100,000 |
Top Partner Programs
Johns Hopkins University:
$223,779,120
View countries
Baylor College of Medicine:
$52,783,455
View countries